Lacosamide 72603-0305
Product NDC
72603-0305- Manufacturer
- Northstar Rx Llc
- Dosage Form
- Solution
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- June 1, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA209224
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 10 mg/mL |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(1)
200 mL in 1 BOTTLE, PLASTIC (72603-305-01)